Anticoagulation control in different ethnic groups receiving vitamin K antagonist therapy for stroke prevention in atrial fibrillation

Efficacy and safety of vitamin K antagonists (VKAs) is optimised in atrial fibrillation (AF) patients when the International Normalised Ratio (INR) is 2.0 –3.0. Anticoagulation control comparing different ethnic groups is limited, although epidemiological studies suggest poorer INR control in non-white cohorts.

Source: Thrombosis Research - May 5, 2020 Category: Hematology Authors: Hanis Zulkifly, Paola Cheli, Ivana Lutchman, Ying Bai, Gregory Y.H. Lip, Deirdre A. Lane Tags: Full Length Article Source Type: research